In vitro study of the interaction between artemether-lumefantrine and ciprofloxacin/metronidazole
Paper Details
In vitro study of the interaction between artemether-lumefantrine and ciprofloxacin/metronidazole
Abstract
This study investigated the in vitro interactions between artemether-lumefantrine and ciprofloxacin or metronidazole in their co-administration. Commercial brands of artemether-lumefantrine, ciprofloxacin and metronidazole tablets were evaluated for some physical properties such as organoleptics, dimensions, weight uniformity, crushing strength and friability. The effects of their interactions on the disintegration times and drug release profiles of artemether-lumefantrine, metronidazole, and ciprofloxacin tablets were investigated. Interaction studies using Fourier transform infra-red (FTIR) analysis were also carried out. All the commercial brands of tablets used in the study met BP specifications in their weight uniformity, friability (≤ 1.0%), and crushing strengths (5.0 – 12.0 kgF). There was no significant (p ≥ 0.05) effect on the disintegration times of artemether-lumefantrine tablet in the presence of ciprofloxacin or metronidazole and vice versa. However, there was significant (p ≤ 0.05) retardation of artemether-lumefantrine release in the presence of ciprofloxacin or metronidazole. FTIR analysis showed no appreciable shift in spectral bands of artemether-lumefantrine in the presence of ciprofloxacin or metronidazole. The in vitro interaction between tablet formulations of artemether-lumefantrine and ciprofloxacin or metronidazole and vice versa, showed that a more drug release retardation is seen between artemether-lumefantrine and metronidazole than with ciprofloxacin and these changes in drug release indicated an absorption interaction, possibly due to alteration in gastric pH.
Abamecha A, Yilma D, Adissu W, Yewhalaw D, Abdissa A. 2021. Efficacy and safety of artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Ethiopia: a systematic review and meta-analysis. Malaria Journal 20, 213. https://doi.org/10.1186/s12936-021-03745-8.
Adeoye-Isijola MO, Osopale BA, Olajuyigbe OO. 2019. In vitro influence of metronidazole on the activities of ciprofloxacin against clinically important bacterial isolates. GSC Biological and Pharmaceutical Sciences 6, 31-39. https://doi.org/10.30574/gscbps.2019.6.3.0006.
Aly EM, Sabry HY, Fahmy ZH, Zalat RS. 2014. Efficacy of combination therapy (metronidazole and/or artemether) in experimental giardiasis and its impact on non-enzymatic oxidative stress biomarkers. Parasitologists United Journal 7, 68-74. https://doi.org/10.4103/1687-7942.139692.
Awofisayo SO, Arhewoh MI, Okhamafe AO. 2018. In vitro interaction studies between artemether-lumefantrine and lamivudine/metronidazole. International Journal of Current Research and Review 10, 25-30.
Awofisayo SO, Umoh EE, Igwe CN, Ojobor PD. 2017. Effect of metronidazole on piperaquine permeability from dihydroartemisinin-piperaquine antimalarial product across intestinal membranes. Saudi Journal of Pharmaceutical Sciences 3, 862-867. https://doi.org/10.21276/sjmps.
British Pharmacopoeia. 2009. British Pharmacopoeia Commission. Vol. III. London: Stationery Office Limited, pp. 6578-6585.
Brody T. 2018. Drug-drug interactions: Part one (small molecule drugs). FDA’s Drug review process and the package label. Cambridge: Academic Press, p. 355.
Ezenduka CC, Ogbonna BO, Ekwunife OI, Okonta MJ, Esimone CO. 2014. Drugs use pattern for uncomplicated malaria in medicine retail outlets in Enugu urban, southeast Nigeria: implications for malaria treatment policy. Malaria Journal 13, 243. https://doi.org/10.1186/1475-2875-13-243.
Fomba S, Koné D, Doumbia B, Diallo D, Druetz T, Florey L, Eisele TP, Eckert E, Mihigo J, Ashton RA. 2020. Management of uncomplicated malaria among children under five years at public and private sector facilities in Mali. BMC Public Health 20, 1888. https://doi.org/10.1186/s12889-020-09873-1.
Gonzales MLM, Dans LF, Sio-Aguilar J. 2019. Antiamoebic drugs for treating amoebic colitis. Cochrane Database of Systematic Reviews 1, CD006085. https://doi.org/10.1002/14651858.CD006085.pub3.
Han K, Cao P, Wang Y, Xie F, Ma J, Yu M,Wang J, Xu Y, Zhang Y, Wan J. 2022. A review of approaches for predicting drug-drug interactions based on machine learning. Frontiers in Pharmacology 12, 814858. https://doi.org/10.3389/fphar.2021.814858.
Jimam NS, Dayom WD, Jingina MY, Mohammed UD. 2019. Prescription patterns of antimalarial medicines in selected primary health care (PHC) facilities of Jos North Local Government Area (LGA) of Plateau State, Nigeria. European Journal of Biotechnology and Bioscience 7, 66-70.
Ntamabyaliro NY, Burri C, Nzolo DB, Engo AB, Lula YN, Mampunza SM, Nsibu CN, Mesia GK, Kayembe JN, Likwela JL, Kintaudi LM, Tona GL. 2018. Drug use in the management of uncomplicated malaria in public health facilities in the Democratic Republic of the Congo. Malaria Journal 17, 189. https://doi.org/10.1186/s12936-018-2332-3.
Oyinaka BD, Umar NM, Aminu N, Akinleye CA, Nuhu T. 2021. Knowledge and attitude of primary healthcare workers towards rational prescription of artemisinin-based combination therapy in the treatment of uncomplicated malaria in Ondo State, southwestern Nigeria. Journal of Pre-Clinical and Clinical Research 15, 5-14. https://doi.org/10.26444/jpccr/131762
Palleria C, Di Paolo A, Giofrè C, Caglioti C, Leuzzi G, Siniscalchi A, De Sarro G, Gallelli L. 2013. Pharmacokinetic drug-drug interaction and their implication in clinical management. Journal of Research in Medical Sciences 18, 601-610.
Peng Y, Cheng Z, Xie F. 2021. Evaluation of pharmacokinetic drug-drug interactions: a review of the mechanisms, in vitro and in silico approaches. Metabolites, 11, 75. https://doi.org/10.3390/metabo11020075.
Pham TDM, Ziora ZM, Blaskovich MAT. 2019. Quinolone antibiotics. MedChemComm 10, 1719-1739.
Sümer S, Ural G, Ural O. 2014. Plasmodium falciparum and Salmonella typhi co-infection: a case report. Mikrobiyoloji Bulteni 48, 174-178. https://doi.org/10.5578/mb.5661.
Uzochukwu BS, Chiegboka LO, Enwereuzo C, Nwosu U, Okorafor D, Onwujekwe OE, Uguru NP, Sibeudu FT, Ezeoke OP. 2010. Examining appropriate diagnosis and treatment of malaria: Availability and use of rapid diagnostic tests and artemisinin-based combination therapy in public and private health facilities in Southeast Nigeria. BMC Public Health 10, 486. https://doi.org/10.1186/1471-2458-10-486.
Wienkers LC, Heath TG. 2005. Predicting in vivo drug interactions from in vitro drug discovery data. Nature Reviews Drug Discovery 4, 825-433. https://doi.org/10.1038/nrd1851.
World Health Organization. 2015. Guidelines for the treatment of malaria. 3rd ed. Geneva: World Health Organization; [cited 2023 Jun 26]. p. 361. https://www.afro.who.int/publications/guidelines-treatment-malaria-third-edition.
Sylvester O. Eraga, Paul G. Okoro, Ogochukwu A. Meko, Nkeiruka G. Osuafor, Emmanuel Agbamu, Matthew I. Arhewoh, 2025. In vitro study of the interaction between artemether-lumefantrine and ciprofloxacin/metronidazole. Int. J. Biomol. Biomed., 21(1), 12-20.
Copyright © 2025 by the Authors. This article is an open access article and distributed under the terms and conditions of the Creative Commons Attribution 4.0 (CC BY 4.0) license.